Skip to main content

Table 4 Number of patients reporting side-effects at any time point after drug administration in Yunnan Province, China

From: Artemisinin-naphthoquine combination versus chloroquine-primaquine to treat vivax malaria: an open-label randomized and non-inferiority trial in Yunnan Province, China

 

ANQ (n = 127)

CQ-PQ (n = 128)

P-value

Adverse response

25 (19.7%)

24 (18.8%)

0.97

Dizziness

1 (0.8%)

1 (0.8%)

-

Nausea

9 (7.1%)

7 (5.5%)

0.59

Anorexia

9 (7.1%)

7 (5.5%)

0.59

Diarrhoea

2 (1.6%)

1 (0.8%)

0.99

Abdominal pain

1 (0.8%)

1 (0.8%)

-

Palpitations

0 (0.0%)

1 (0.8%)

-

Headache

0 (0.0%)

2 (1.6%)

-

Vomiting

3 (2.4%)

2 (1.6%)

0.99

Haemolysis

0 (0.0%)

2 (1.6%)

-